ContraVir Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
ContraVir Pharmaceuticals, Inc.
CIK #0001583771
EDGAR Form CIK 2011 - 2023
10-K [0001583771]
10-Q [0001583771]
3 [0001583771]
4 [0001583771]
8-K [0001583771]
D [0001583771]
SC 13D [0001583771]
SC 13G [0001583771]
Form 13D/13G Filer Form 13D/13G Subject Filed
Altium Capital Management LP Hepion Pharmaceuticals Inc [2021-02-24]
Sabby Management LLC Hepion Pharmaceuticals Inc [2021-02-19]
Empery Asset Management LP Hepion Pharmaceuticals Inc [2021-02-18]
Vanguard Group Inc Hepion Pharmaceuticals Inc [2021-02-10]
Hirschman Orin Hepion Pharmaceuticals Inc [2020-12-09]
Empery Asset Management LP Hepion Pharmaceuticals Inc [2020-12-02]
Sabby Management LLC Hepion Pharmaceuticals Inc [2020-12-02]
Hudson Bay Capital Management LP Hepion Pharmaceuticals Inc [2020-02-05]
Anson Funds Management LP Contravir Pharmaceuticals Inc [2019-06-28]
CVI Investments Inc Contravir Pharmaceuticals Inc [2019-06-27]
View All
Form 3/4/5 Subject 2011 - 2023
Lbiati Kaouthar
Hepion Pharmaceuticals, Inc.
Reddi Anand
Wijngaard Peter
Jacob Gary S
Foster Robert T
Cavan John T
Brancaccio John P
Adams Thomas PhD
Block Timothy M.
View All
Terms | Privacy | Guide
tony@aum13f.com